A comprehensive review of small molecule drugs approved by the FDA in 2024: Advance and prospect

A comprehensive review of small molecule drugs approved by the FDA in 2024: Advance and prospect

Yi-Ru Bai, Qing-Chuan Duan, Dong-Jie Seng, Ying Xu, Hong-Bo Ren, Jie Zhang, Dan-Dan Shen, Li Yang, Hong-Min Liu, Shuo Yuan

PDF(18069 KB)

　

Search
Submit
E-mail
RSS

Chinese Chemical Letters ›› 2025, Vol. 36 ›› Issue (10) : 111025. DOI: 10.1016/j.cclet.2025.111025

Reviews

A comprehensive review of small molecule drugs approved by the FDA in 2024: Advance and prospect

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 36(10): 111025 https://doi.org/10.1016/j.cclet.2025.111025

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(18069 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉